Noun
ibrutinib (uncountable)
A targeted covalent inhibitor of Bruton's tyrosine kinase and hence used in treating B cell malignancies.
Additionally, during the third quarter of 2013, the Company expects to record a gain on sale of the Ibrutinib royalty rights of approximately per share. Source: Internet